Bio Medica Laboratories Limited (NSE:BMLL)
India · Delayed Price · Currency is INR 140.35
+6.75 (5.05%)
At close: Jun 18, 2026
Bio Medica Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 0.07 | 0.1 | 0.06 | 15.28 | 0.37 |
Cash & Short-Term Investments | 0.07 | 0.1 | 0.06 | 15.28 | 0.37 |
Cash Growth | -34.13% | 68.20% | -99.60% | 4063.83% | 206.92% |
Accounts Receivable | 41 | 23.36 | 40.73 | 54.47 | 30.04 |
Other Receivables | - | 0.4 | - | - | - |
Receivables | 41 | 23.76 | 40.73 | 57.58 | 30.35 |
Inventory | 181.38 | 73.67 | 39.02 | 23.28 | 29.61 |
Prepaid Expenses | 0.34 | - | - | - | - |
Other Current Assets | 88.12 | 6.75 | 9.03 | 6.35 | 10.08 |
Total Current Assets | 310.91 | 104.29 | 88.84 | 102.49 | 70.4 |
Property, Plant & Equipment | 74.61 | 87.27 | 83.11 | 70.99 | 50.75 |
Long-Term Deferred Tax Assets | 2.17 | 1.08 | 0.26 | 0.28 | 0.25 |
Other Long-Term Assets | 3.49 | 1.31 | 3.19 | 0.79 | - |
Total Assets | 391.18 | 193.95 | 175.4 | 174.55 | 121.4 |
Accounts Payable | 42.78 | 21.59 | 47.98 | 36.16 | 35.97 |
Accrued Expenses | 9.47 | 2.92 | 1.6 | - | 2.21 |
Short-Term Debt | 63.56 | 17.33 | 37.33 | 68.41 | 33.62 |
Current Portion of Long-Term Debt | 18.94 | 9.91 | 12.03 | - | 4.17 |
Current Income Taxes Payable | 34.52 | 10.22 | 1.26 | 2.11 | 1.58 |
Other Current Liabilities | 0.69 | 0.87 | 1.37 | 3.14 | 0.64 |
Total Current Liabilities | 169.94 | 62.85 | 101.57 | 109.81 | 78.19 |
Long-Term Debt | 67.65 | 77.66 | 46.7 | 41.2 | 25.57 |
Pension & Post-Retirement Benefits | 3.16 | - | - | - | - |
Other Long-Term Liabilities | 3.1 | 0 | 0 | - | 0 |
Total Liabilities | 243.85 | 140.5 | 148.27 | 151.01 | 103.76 |
Common Stock | 91.8 | 1 | 1 | 1 | 1 |
Retained Earnings | 55.53 | 52.45 | 26.13 | 22.54 | 16.65 |
Shareholders' Equity | 147.33 | 53.45 | 27.13 | 23.54 | 17.65 |
Total Liabilities & Equity | 391.18 | 193.95 | 175.4 | 174.55 | 121.4 |
Total Debt | 150.14 | 104.9 | 96.07 | 109.6 | 63.36 |
Net Cash (Debt) | -150.08 | -104.8 | -96.01 | -94.32 | -62.99 |
Net Cash Per Share | -16.35 | -11.42 | -10.46 | -10.27 | -6.86 |
Filing Date Shares Outstanding | 9.18 | 9.18 | 9.18 | 9.18 | 9.18 |
Total Common Shares Outstanding | 9.18 | 9.18 | 9.18 | 9.18 | 9.18 |
Working Capital | 140.97 | 41.44 | -12.73 | -7.32 | -7.79 |
Book Value Per Share | 16.05 | 5.82 | 2.96 | 2.56 | 1.92 |
Tangible Book Value | 147.33 | 53.45 | 27.13 | 23.54 | 17.65 |
Tangible Book Value Per Share | 16.05 | 5.82 | 2.96 | 2.56 | 1.92 |
Land | 56.57 | 55.19 | 47.78 | - | 36.1 |
Machinery | 56.49 | 62.46 | 54.61 | - | 25.67 |